CHAOSTOCOSMOS

Wednesday, 17 June 2015

Brief Report From Dr. Prigden on the Fibromyalgia Antiviral Trial

It’s not too much to say that if successful, the Pridgen antiviral trials for Fibromyalgia would be a paradigm changer – turning FM from a poorly treated central nervous system disorder to a disorder characterized by a (hopefully) treatable herpesvirus infection.
Is it a breakthrough? The results look good so far - stay tuned!

Is it a breakthrough? The results look good so far – stay tuned!

Pridgen’s approach is new in several ways. Not only has no one targeted herpesviruses in FM before, but the herpesvirus Pridgen is targeting, herpes simplex virus, is one no one has connected with either FM or ME/CFS before.



Brief
Report From Dr. Prigden on the Fibromyalgia Antiviral Trial - and the
Future Chronic Fatigue Syndrome One - Simmaron ResearchSimmaron Research

No comments:

Related Posts Plugin for WordPress, Blogger...
^ Top